English
العربية
Français
Português
Español
Uzbek
Myanmar
Medicine Manufacturer Vietnam — Vinphaco’s Commitment to Healthcare Beyond the Factory
When international partners evaluate a medicine manufacturer in Vietnam, manufacturing capability and quality systems are naturally important considerations. But understanding a pharmaceutical company also means looking at how it engages with the wider healthcare ecosystem.
Pharmaceutical manufacturing does not exist in isolation.
Medicines are developed, manufactured, distributed, prescribed, dispensed, and ultimately used within a healthcare system. For pharmaceutical manufacturers, maintaining meaningful connections with healthcare professionals can therefore provide an opportunity to better understand the clinical environment in which medicines are used.
This perspective was reflected in the Vinphaco Speaker Tour 2026, held on June 18, 2026, at Bac Ninh General Hospital No. 2.
The program brought together nearly 100 healthcare professionals from the Bac Ninh region and three of Vietnam’s leading respiratory medicine specialists for a full-day clinical knowledge exchange program.
This is one example of how a pharmaceutical manufacturer can engage with the healthcare community beyond its manufacturing operations — by supporting professional knowledge exchange and creating opportunities for healthcare professionals to share clinical perspectives.
Vinphaco Speaker Tour 2026 — Connecting Clinical Knowledge and Healthcare Practice
The Bac Ninh session of the Vinphaco Speaker Tour 2026 was hosted at Bac Ninh General Hospital No. 2 and chaired by Senior Specialist Doctor Nguyen Dang Hung, Deputy Director of the hospital.
The program brought together healthcare professionals working across four interconnected specialties:
- Respiratory Medicine
- Internal Medicine
- Emergency Medicine
- Intensive Care
This cross-specialty approach reflects the multidisciplinary nature of respiratory disease management in clinical practice.
Patients with respiratory conditions may require different levels of care depending on disease severity and clinical circumstances. Collaboration among respiratory physicians, internists, emergency physicians, intensivists, and other healthcare professionals can therefore play an important role in patient management.
By creating a forum for clinical knowledge exchange across these specialties, the program provided an opportunity for healthcare professionals to discuss respiratory care from different clinical perspectives.
Featured Speakers — Vietnam’s Respiratory Medicine Leadership
The clinical content of the Vinphaco Speaker Tour 2026 session was delivered by three of Vietnam’s leading respiratory medicine specialists.
Dr. Nguyen Thi Bich Ngoc, PhD
Dr. Nguyen Thi Bich Ngoc is Director of the Center for Rare Lung Diseases and Respiratory Infections at the National Lung Hospital in Hanoi.
Her area of expertise includes complex respiratory conditions and respiratory infections, areas that require careful diagnosis and appropriate clinical management.
MSc. Vu Van Thanh, MD
MSc. Vu Van Thanh is Head of the Chronic Lung Disease Department at the National Lung Hospital.
Chronic respiratory diseases, including COPD and bronchial asthma, are important areas of respiratory care. For asthma management, the 2026 GINA Strategy Report provides an updated evidence-based resource for healthcare professionals.
Senior Specialist II Nguyen Phuong Mai, MSc.
Senior Specialist II Nguyen Phuong Mai is Head of the Respiratory Internal Medicine Department at Bac Ninh General Hospital No. 2.
As a representative of the host institution, Dr. Mai provided an important connection between specialist respiratory knowledge and the practical clinical environment at the provincial hospital level.
Together, the three speakers brought perspectives from specialist respiratory care, chronic lung disease management, and clinical practice in a provincial healthcare setting.
Why Clinical Education Matters When Choosing a Medicine Manufacturer Vietnam
For international pharmaceutical companies, importers, distributors, and healthcare partners evaluating a medicine manufacturer in Vietnam, clinical engagement can provide another perspective on the manufacturer’s relationship with the healthcare ecosystem.
A pharmaceutical manufacturer operates within a broader network that includes healthcare professionals, hospitals, regulatory authorities, distributors, pharmacies, and patients.
Understanding this ecosystem matters.
Medical education and professional knowledge exchange do not replace clinical guidelines, scientific evidence, or regulatory requirements. However, they can create opportunities for healthcare professionals to discuss developments in their fields, exchange practical experience, and strengthen professional knowledge.
For pharmaceutical manufacturers, engagement with healthcare professionals can also provide a better understanding of the clinical context in which medicines are used.
This is particularly relevant for companies working across different therapeutic areas and international markets, where healthcare systems and clinical practices may vary.
A pharma Vietnam healthcare partnership is therefore not simply about supplying pharmaceutical products. Long-term relationships are also built through communication, professional understanding, quality, and a shared commitment to supporting healthcare needs.
Pharmaceutical Company Vietnam Medical Education — Beyond Product Supply
The role of a pharmaceutical company extends beyond manufacturing and distribution.
Quality is influenced by many interconnected elements — from product development and raw materials to manufacturing processes, quality control, regulatory compliance, distribution, and ultimately appropriate use.
For this reason, pharmaceutical companies benefit from understanding the environment in which their medicines are used.
This includes understanding:
- The therapeutic areas in which products are used
- The healthcare professionals involved in patient care
- The clinical challenges faced by hospitals and healthcare facilities
- The differences between healthcare systems across markets
- The importance of responsible and evidence-based medical communication
The relationship between pharmaceutical manufacturing and healthcare is therefore broader than the production line.
The manufacturing facility is where medicines are produced. The healthcare environment is where those medicines ultimately become part of patient care.
Understanding both sides is important for a pharmaceutical company seeking to develop sustainable relationships with healthcare professionals and international partners.
Respiratory Medicine Vietnam — A Field That Requires Multidisciplinary Collaboration
The clinical focus of the Bac Ninh session reflects the importance of respiratory medicine within modern healthcare. WHO’s overview of lung health highlights the importance of prevention, early diagnosis, and appropriate management across a range of respiratory conditions.
Respiratory conditions can involve different levels of clinical complexity and may require collaboration across specialties.
A patient may first present in an outpatient setting, require assessment by an internal medicine or respiratory specialist, or need emergency or intensive care depending on the severity of the condition.
This makes multidisciplinary clinical knowledge particularly relevant.
For a medicine manufacturer in Vietnam, understanding this clinical environment provides useful context for how pharmaceutical products fit into broader healthcare pathways.
At the same time, pharmaceutical manufacturers must recognize the boundaries of their role. Clinical decisions remain the responsibility of qualified healthcare professionals and should be guided by appropriate evidence, approved product information, and applicable clinical guidelines.
For COPD management, international clinical resources such as the 2026 GOLD Report and Pocket Guide provide evidence-based guidance for prevention, diagnosis, and management.
The contribution of a pharmaceutical company is to support the healthcare ecosystem through quality manufacturing, responsible communication, reliable supply, and appropriate engagement with healthcare stakeholders.
From Clinical Engagement to Pharmaceutical Manufacturing
VINPHACO’s current manufacturing system covers a broad range of pharmaceutical dosage forms.
According to the current Company Profile, VINPHACO operates three sterile production workshops with capabilities including solution injectable and infusion products, aerosols, and lyophilized injectables.
Its BFS workshop includes production capabilities for injectable products, eye drops, nasal drops, ear drops, and aerosol products.
The company’s non-sterile and herbal/traditional medicine manufacturing operations include softgel capsules, liquid dosage forms, tablets, hard capsules, powders, and granules.
The Company Profile presents a quality management framework including GMP-WHO, GLP, GSP, GDP, ISO 9001:2015, and SAP S/4HANA. Specific certification scope and current status should always be considered in relation to the relevant manufacturing facility, product, and target market.
For international partners looking for a GMP-WHO Vietnam manufacturer, manufacturing capabilities and quality systems are important parts of the evaluation process.
However, a potential long-term pharmaceutical partnership may also involve other considerations, including product portfolio, regulatory requirements, supply capabilities, communication, and understanding of the healthcare environment.
These factors are interconnected.
VINPHACO Vietnam — Connecting Manufacturing, Healthcare, and International Development
VINPHACO has more than 66 years of development and operates a diverse pharmaceutical manufacturing system covering sterile, BFS, non-sterile, and herbal/traditional medicine production.
According to the current Company Profile, nearly 100 products are marketed in more than 20 countries worldwide. The company’s distribution network also includes 800 hospitals and healthcare facilities, 1,000 private clinics, and 10,000 pharmacies.
For an international pharmaceutical business, these capabilities provide an important foundation.
But long-term pharmaceutical partnerships are built on more than manufacturing capacity.
They are also built through understanding.
Understanding products.
Understanding manufacturing and quality requirements.
Understanding regulatory considerations.
Understanding market conditions.
And understanding the healthcare environment in which medicines are ultimately used.
The Vinphaco Speaker Tour 2026 represents one example of how clinical knowledge exchange can complement the broader role of a pharmaceutical manufacturer.
For VINPHACO, the connection between pharmaceutical manufacturing and healthcare extends beyond the factory gate and into the professional communities that work every day to improve patient care.
As the Speaker Tour continues across additional provinces and specialties throughout 2026, the underlying principle remains relevant: pharmaceutical partnerships are stronger when they are built not only around products and supply, but also around knowledge, professional collaboration, and a shared understanding of healthcare needs.
Key Takeaways for International Pharmaceutical Partners
When evaluating a medicine manufacturer in Vietnam, international pharmaceutical companies, importers, distributors, and procurement partners may consider several interconnected areas:
1. Manufacturing Capability
Does the manufacturer have relevant production capabilities for the required dosage forms and products?
2. Quality Systems
Are the manufacturer’s quality systems and applicable GMP standards aligned with the requirements of the target market and specific products?
3. Healthcare Understanding
Does the company understand the clinical and healthcare environment in which its medicines are used?
4. Professional Engagement
Does the company maintain appropriate engagement with healthcare professionals and contribute to professional knowledge exchange?
5. Long-Term Partnership
Can the relationship develop beyond individual transactions toward a sustainable partnership based on quality, communication, technical understanding, and market requirements?
For a GMP-WHO Vietnam manufacturer serving both domestic and international markets, the ability to connect manufacturing knowledge with a broader understanding of healthcare can be an important part of long-term development.
The role of a pharmaceutical manufacturer does not end when a medicine leaves the production line.
It continues through the wider healthcare ecosystem — where quality, professional knowledge, responsible communication, and collaboration ultimately come together to support patient care.
